Biology > Presentation > PEDS 602 Cardiac_Drip_Presentation_2020 | PEDS602 Cardiac_Drip_Presentation_PEDS 602 Cardiac_Drip_Pr (All)

PEDS 602 Cardiac_Drip_Presentation_2020 | PEDS602 Cardiac_Drip_Presentation_PEDS 602 Cardiac_Drip_Presentation_2020 | PEDS602 Cardiac_Drip_Presentation_NEW VERSION VERSION

Document Content and Description Below

PEDS 602 Cardiac_Drip_Presentation_2020 Cardiac Medications Used in the Critical Care Unit ALEXANDRA ANGEL, PHARM.D. PHARMACY RESIDENT WEST KENDALL BAPTIST HOSPITALObjectives  Provide an over... view for the management of vasoactive medications  Apply knowledge and concepts in the initiation, administration, and monitoring of therapy for patients receiving vasoactive medications  Discuss overall rationale and management for vasoactive medicationsOutline  Adrenergic receptor physiology  Medication therapy in:  Hypotension (i.e., shock)  Hypertension Emergencies  Acute Decompensated Heart Failure  Arrhythmias  Review of:  Vasopressors and Inotropes  Vasodilators  Anti-arrhythmics  Other Cardiac medicationsVasoactive Therapy CO: Cardiac Output SVR: Systemic Vascular ResistanceVasopressorsVasopressors  Norepinephrine (NE) – Levophed®  Epinephrine (Epi) – Adrenalin®  Dopamine (DA) – Intropin®  Phenylephrine – Neosynephrine  Dobutamine – Dobutrex®  Vasopressin – Vasostrict®Vasopressors  Induce vasoconstriction → ↑ mean arterial pressure (MAP)  Some agents may have both vasopressor and inotropic effects  Inotropes that ↑ cardiac contractility  Dopamine  DobutamineAdrenergic Receptor Physiology Receptor Location Physiologic Effect Alpha-1 (α1) Vascular walls • Vasoconstriction (significant) • Heart: ↑ duration of contraction without ↑ chronotropic effects Beta-1 (β1) Heart • ↑ inotropic & chronotropic effects with minimal vasoconstriction Beta-2 (β2) Lungs • Vasodilation Dopamine (DA) Renal, mesenteric, coronary, and cerebral vascular beds • Vasodilation • Stimulates DA receptors → vasoconstriction inducing NE releaseIndications for Vasopressors  End-Organ dysfunction due to hypo-perfusion AND either one of the following:  Decrease of > 30mmHg from baseline SBP  MAP < 60mmHg- - - - - [Show More]

Last updated: 1 year ago

Preview 1 out of 67 pages

Add to cart

Instant download

document-preview

Buy this document to get the full access instantly

Instant Download Access after purchase

Add to cart

Instant download

Reviews( 0 )

$13.50

Add to cart

Instant download

Can't find what you want? Try our AI powered Search

OR

REQUEST DOCUMENT
83
0

Document information


Connected school, study & course


About the document


Uploaded On

Jun 13, 2021

Number of pages

67

Written in

Seller


seller-icon
Elli

Member since 3 years

68 Documents Sold


Additional information

This document has been written for:

Uploaded

Jun 13, 2021

Downloads

 0

Views

 83

Document Keyword Tags


$13.50
What is Browsegrades

In Browsegrades, a student can earn by offering help to other student. Students can help other students with materials by upploading their notes and earn money.

We are here to help

We're available through e-mail, Twitter, Facebook, and live chat.
 FAQ
 Questions? Leave a message!

Follow us on
 Twitter

Copyright © Browsegrades · High quality services·